FORM 4
[ ] Check this box if no longer
subject to Section 16. Form 4 or Form
5 obligations may continue.
See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number: 3235-0287
Expires: December 31, 2001
Estimated average burden
hours per response. . . . . 0.5

1. Name and Address of Reporting Person^*
SCHIFF, GILBERT MARLIN

(Last) (First) (Middle)520 CHISHOLM TR.

(Street)CINCINNATI, OH 45215

(City) (State) (Zip)USA

2. Issuer Name and Ticker
or Trading Symbol

ZYMETX, INC. ZMTX

3. I.R.S. Identification
    Number of Reporting
    Person, if an entity
    (voluntary)

4. Statement for
(Month/Year)

November 2001

5. If Amendment,
Date of Original
(Month/Year)

6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer Other

Officer/Other
Description

7. Individual or Joint/Group
Filing (Check Applicable Line)

X Individual Filing
Joint/Group Filing

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	3. Transaction Code and Voluntary Code (Instr. 8) Code \| V	4. Securities Acquired (A) or Disposed (D) Of (Instr. 3, 4, and 5) Amount \| A/D \| Price	5. Amount of Securities Beneficially Owned at End of Month (Instr. 3 and 4)	6. Owner- ship Form: Direct(D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

(over)
SEC 1474 (3-99)

SCHIFF, GILBERT MARLIN - November 2001

Form 4 (continued)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conver- sion or Exercise Price of Deri- vative Security	3. Transaction Date (Month/ Day/ Year)	4. Transaction Code and Voluntary (V) Code (Instr.8) Code \| V	5. Number of Derivative Securities Acquired (A) or Disposed (D) Of (Instr. 3,4 and 5)	6. Date Exercisable(DE) and Expiration Date(ED) (Month/Day/Year) (DE) \| (ED)	7. Title and Amount of Underlying Securities (Instr. 3 and 4)	8. Price of Derivative Security (Instr.5)	9. Number of Derivative Securities Beneficially Owned at End of Month (Instr.4)	10. Owner- ship Form of Deriv- ative Security: Direct (D) or Indirect (I)	11. Nature of Indirect Beneficial Ownership (Instr.4)
Common Stock Purchase Warrant	$0.30	11/16/2001	A (1) \|	(A) 12,500.00	11/16/2001 \| 11/15/2006	COMMON STOCK, par value $.001 - 12,500.00	$0.30	12,500.00	D
Non-Qualified Stock Options 1-96	$1.00				01/03/1997 \| 01/03/2006	COMMON STOCK, par value $.001 - 25,000.00		25,000.00	D

Explanation of Responses :

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB number.

________________________________ 12-10-2001
** Signature of Reporting Person Date

/s/ Gilbert M. Schiff
GILBERT MARLIN SCHIFF

Page 2
SEC 1474 (3-99)

SCHIFF, GILBERT MARLIN - November 2001

Form 4 (continued)

FOOTNOTE Descriptions for ZYMETX, INC. ZMTX

Form 4 - November 2001

GILBERT MARLIN SCHIFF
520 CHISHOLM TR.

CINCINNATI, OH 45215
Explanation of responses:

(1) Warrants were issued in connection with Dr. Schiff's purchase in a private placement that closed on November 16, 2001, of 1/2 Unit, each unit consisting of a $25,000 principle amount, 12% promissory note and warrants to purchase 25,000 shares of common stock at an exercise price of $.30 per share.

Page 3

ZYMETX INC 4